Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: Almirall, S.A., Ronda General Mitre, 151, 08022, Barcelona, Spain
Vaniqa 11.5% cream.
| Pharmaceutical Form |
|---|
|
Cream. White to off white cream. |
Each gram of cream contains 115 mg of eflornithine (as hydrochloride monohydrate).
Excipients with known effect: Each gram of cream contains 47.2 mg of cetostearyl alcohol, 14.2 mg of stearyl alcohol, 0.8 mg of methyl parahydroxybenzoate and 0.32 mg of propyl parahydroxybenzoate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Eflornithine |
Eflornithine irreversibly inhibits ornithine decarboxylase, an enzyme involved in the production of the hair shaft by the hair follicle. Eflornithine has been shown to reduce the rate of hair growth. |
| List of Excipients |
|---|
|
Cetostearyl alcohol |
High density polyethylene tube with a polypropylene screw cap containing 15 g, 30 g or 60 g of cream. Not all pack sizes may be marketed.
Almirall, S.A., Ronda General Mitre, 151, 08022, Barcelona, Spain
EU/1/01/173/001-003
Date of first authorisation: 20 March 2001
Date of latest renewal: 07 March 2011
| Drug | Countries | |
|---|---|---|
| VANIQA | Austria, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
